AU2578588A - Esters of pharmacologically active carboxylic acids - Google Patents
Esters of pharmacologically active carboxylic acidsInfo
- Publication number
- AU2578588A AU2578588A AU25785/88A AU2578588A AU2578588A AU 2578588 A AU2578588 A AU 2578588A AU 25785/88 A AU25785/88 A AU 25785/88A AU 2578588 A AU2578588 A AU 2578588A AU 2578588 A AU2578588 A AU 2578588A
- Authority
- AU
- Australia
- Prior art keywords
- esters
- carboxylic acids
- pharmacologically active
- active carboxylic
- pharmacologically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH4570/87 | 1987-11-24 | ||
CH457087 | 1987-11-24 | ||
CH3165/88 | 1988-08-25 | ||
CH316588 | 1988-08-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2578588A true AU2578588A (en) | 1989-05-25 |
AU614793B2 AU614793B2 (en) | 1991-09-12 |
Family
ID=25692354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25785/88A Ceased AU614793B2 (en) | 1987-11-24 | 1988-11-21 | Esters of pharmacologically active carboxylic acids |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0318767A3 (en) |
JP (1) | JPH01165585A (en) |
KR (1) | KR890008082A (en) |
AU (1) | AU614793B2 (en) |
DK (1) | DK637888A (en) |
FI (1) | FI885330A (en) |
HU (1) | HU207522B (en) |
IL (1) | IL88403A0 (en) |
MC (1) | MC1991A1 (en) |
NO (1) | NO885221L (en) |
NZ (1) | NZ226989A (en) |
PT (1) | PT89080B (en) |
SU (1) | SU1598880A3 (en) |
YU (2) | YU216188A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU654300B2 (en) * | 1990-11-09 | 1994-11-03 | Eisai Co. Ltd. | 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990008354A (en) * | 1995-05-03 | 1999-01-25 | 페터 죤 기딩스 | Ester of carbapenem |
WO2013033450A2 (en) * | 2011-08-31 | 2013-03-07 | Mallinckrodt Llc | Remote assembly of targeted nanoparticles using h-phosphonate-ene/-yne hydrophosphonylation reactions |
EP3616695A1 (en) | 2011-09-09 | 2020-03-04 | Merck Sharp & Dohme Corp. | Methods for treating intrapulmonary infections |
US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
KR102329764B1 (en) | 2013-03-15 | 2021-11-23 | 머크 샤프 앤드 돔 코포레이션 | Ceftolozane antibiotic compositions |
US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
EP3043797B1 (en) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2476087A1 (en) * | 1980-02-18 | 1981-08-21 | Roussel Uclaf | NOVEL OXIMES DERIVED FROM 3-ALKYLOXY OR 3-ALKYL-THIOMETHYL 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS |
JPS5984889A (en) * | 1982-11-05 | 1984-05-16 | Sumitomo Chem Co Ltd | Cephalosporin derivative and its preparation |
-
1988
- 1988-11-15 DK DK637888A patent/DK637888A/en not_active Application Discontinuation
- 1988-11-17 NZ NZ226989A patent/NZ226989A/en unknown
- 1988-11-17 IL IL88403A patent/IL88403A0/en unknown
- 1988-11-17 FI FI885330A patent/FI885330A/en not_active Application Discontinuation
- 1988-11-17 EP EP19880119145 patent/EP0318767A3/en not_active Withdrawn
- 1988-11-21 MC MC882016A patent/MC1991A1/en unknown
- 1988-11-21 AU AU25785/88A patent/AU614793B2/en not_active Ceased
- 1988-11-21 HU HU885974A patent/HU207522B/en unknown
- 1988-11-21 JP JP63292541A patent/JPH01165585A/en active Pending
- 1988-11-22 KR KR1019880015325A patent/KR890008082A/en not_active Application Discontinuation
- 1988-11-23 SU SU884356966A patent/SU1598880A3/en active
- 1988-11-23 NO NO88885221A patent/NO885221L/en unknown
- 1988-11-24 PT PT89080A patent/PT89080B/en not_active IP Right Cessation
- 1988-11-24 YU YU02161/88A patent/YU216188A/en unknown
-
1989
- 1989-10-03 YU YU01915/89A patent/YU191589A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU654300B2 (en) * | 1990-11-09 | 1994-11-03 | Eisai Co. Ltd. | 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation |
Also Published As
Publication number | Publication date |
---|---|
JPH01165585A (en) | 1989-06-29 |
KR890008082A (en) | 1989-07-08 |
YU191589A (en) | 1991-02-28 |
AU614793B2 (en) | 1991-09-12 |
MC1991A1 (en) | 1989-11-30 |
EP0318767A3 (en) | 1991-03-20 |
EP0318767A2 (en) | 1989-06-07 |
FI885330A (en) | 1989-05-25 |
NO885221D0 (en) | 1988-11-23 |
FI885330A0 (en) | 1988-11-17 |
SU1598880A3 (en) | 1990-10-07 |
DK637888A (en) | 1989-05-25 |
HUT48895A (en) | 1989-07-28 |
PT89080A (en) | 1988-12-01 |
DK637888D0 (en) | 1988-11-15 |
HU207522B (en) | 1993-04-28 |
IL88403A0 (en) | 1989-06-30 |
NO885221L (en) | 1989-05-25 |
NZ226989A (en) | 1992-05-26 |
PT89080B (en) | 1993-04-30 |
YU216188A (en) | 1990-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4596389A (en) | Ester production by hydrogenation of carboxylic acids and anhydrides | |
HU9300776D0 (en) | Carboxylic acid esters of rapamycine | |
HK1005447A1 (en) | Biologically active carboxylic acid esters | |
GB8719886D0 (en) | Carboxylic acid esters/acids | |
AU2578588A (en) | Esters of pharmacologically active carboxylic acids | |
AU572131B2 (en) | Production of unsaturated carboxylic acids and/or esters | |
AU558806B2 (en) | Production of carboxylic acids and esters | |
AU569584B2 (en) | Preparation of carboxylic acids and esters | |
DE3569931D1 (en) | Carboxylic acid ester derivatives of deglucoteicoplanin | |
GB2194944B (en) | Preparation of unsaturated carboxylic acid esters | |
JPS6471838A (en) | Manufacture of carboxylic acid ester | |
GB8722743D0 (en) | Preparation of esters of carboxylic acids | |
AU5882186A (en) | 3-(substituted)propenylaminothiazol-ylcephalosporanic acids and esters thereof | |
HUT39411A (en) | Process for producing active esters of carboxylic acids | |
AU569479B2 (en) | Preparation of carboxylic acids and esters | |
AU2014388A (en) | Fluorobenzyl esters of cyclopropane carboxylic acids useful as insecticides | |
HK85194A (en) | Cyclohexyl esters of alpha-fluoro/carboxylic acids | |
AU1148288A (en) | Bicyclic beta-lactam carboxylic acids | |
EP0512848A3 (en) | Enzymatic resolution of alpha-tertiary carboxylic acid esters | |
AU2426884A (en) | Preparation of optically active carboxylic acid esters | |
AU3602584A (en) | Production of carboxylic acids and/or esters | |
ZA888616B (en) | Esters of pharmacologically active carboxylic acids | |
AU1011488A (en) | The production of carboxylic acids and esters thereof | |
GB8803535D0 (en) | Process for preparation of carboxylic acids/esters thereof | |
AU1283488A (en) | Aqueous-dispersed polymer compositions containing cyanoalkyl esters of unsaturated carboxylic acids |